Clinical Trial Update: A Study of TAK-994 in Adults With Narcolepsy [Phase 2]

View source ↗

Summary

A Phase 2 trial of TAK-994 in adults with Narcolepsy Type 1 was terminated, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• TAK-994

Snippet

Sponsor: Takeda | Conditions: Narcolepsy Type 1 (NT 1) | Phase 2 | Status: TERMINATED | Results posted: 2023-12-26